Letter

Details of HPV immunisation need not delay decision

BMJ 2005; 331 doi: 10.1136/bmj.331.7524.1081-a (Published 3 November 2005)
Cite this as: BMJ 2005;331:1081.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Adam Finn, David Baum professor of paediatrics (Adam.Finn@bristol.ac.uk)
  1. Institute of Child Life and Health, Department of Clinical Sciences at South Bristol, University of Bristol, Bristol BS2 8AE

    EDITOR—Lowndes and Gill are upbeat in their appraisal of the future for primary prevention of cervical cancer by immunisation.1 But they then deliver a long list of questions that they suggest should be answered before starting human papillomavirus (HPV) vaccination. For most of their questions, this timing is not supported by recent historical precedent.

    Without doubt …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular